A novel form of recessive limb girdle muscular dystrophy with mental retardation and abnormal expression of α-dystroglycan

Neuromuscular Disorders

Volumn 13, Issue 10, 2003, Pages 771-778

  Dinçer, Pervin ^a   Balci, Burcu ^a   Yuva, Yeliz ^a,b   Talim, Beril ^a   Brockington, Martin ^b   Dinçel, Deniz ^c   Torelli, Silvia ^b   Brown, Sue ^b   Kale, Gülsev ^a   Haliloǧlu, Göknur ^a   Gerçeker, Filiz Özbas ^a   Atalay, Rengül Çetin ^c   Yakicier, Cengiz ^c   Longman, Cheryl ^b   Muntoni, Francesco ^b   Topaloǧlu, Haluk ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c BILKENT UNIVERSITY   (Turkey)

Author keywords

Autosomal recessive limb girdle muscular dystrophy; LGMD2; Mental retardation; Microcephaly; Dystroglycan

Indexed keywords

DYSTROGLYCAN;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BRAIN; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMAGING; IMMUNOCYTOCHEMISTRY; LIMB GIRDLE MUSCULAR DYSTROPHY; LINKAGE ANALYSIS; MALE; MENTAL DEFICIENCY; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; ONSET AGE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

EID: 10744221198     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(03)00161-5     Document Type: Article

References (44)

1. Walton J.N., Nattrass F.J. On the classification, natural history and treatment of the myopathies. Brain. 77:1954;169-231.
2. Bushby K.M.D., Beckmann J.S. Report of the 30th and 31st ENMC international workshop-the limb girdle muscular dystrophies, and proposal for a new nomenclature. Neuromuscul Disord. 5:1995;337-344.
3. Richard I., Broux O., Allamand V., et al. Mutations in the proteolytic enzyme calpain 3 cause limb girdle muscular dystrophy type 2A. Cell. 81:1995;27-40.
4. Bashir R., Britton S., Strachan T., et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb girdle muscular dystrophy type 2B. Nat Genet. 20:1998;37-42.
5. Liu J., Aoki M., Illa I., et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet. 20:1998;31-36.
6. Roberds S.L., Leturcq F., Allamand V., et al. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell. 8:1994;625-633.
7. Bönnemann C.G., Modi R., Noguchi S., et al. Beta sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet. 11:1995;266-273.
8. Lim L.E., Duclos F., Broux O., et al. Beta sarcoglycan (43DAG): characterization and role in limb girdle muscular dystrophy linked to chromosome 4q12. Nat Genet. 11:1995;257-265.
9. Noguchi S., McNally E.M., Othmane K.B., et al. Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy. Science. 270:1995;819-822.
10. Nigro V., Moreira E.S., Piluso G., et al. Autosomal recessive limb girdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ-sarcoglycan gene. Nat Genet. 14:1996;195-198.
11. Moreira E.S., Wiltshire T.J., Faulkner G., et al. Limb girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet. 24:2000;163-166.
12. Frosk P., Weiler T., Nylen E., et al. Limb girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiqutin-ligase gene. Am J Hum Genet. 70:2002;663-672.
13. Hackman P., Vihola A., Haravuori H., et al. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein Titin. Am J Hum Genet. 71:2002;492-500.
14. Brockington M., Blake D., Prandini P., et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan. Am J Hum Genet. 69:2001;1198-1209.
15. Brockington M., Yuva Y., Prandini P., et al. Mutations in the fukutin related protein gene (FKRP) identify Limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet. 10:2001;2851-2859.
16. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 355:1992;696-702.
17. Gesemann M., Cavalli V., Denzer A.J., Brancaccio A., Schumacher B., Ruegg M.A. Alternative splicing of agrin alters its binding to heparin, dystroglycan, and the putative agrin receptor. Neuron. 16:1996;755-767.
18. Chiba A., Matsumura K., Yamada H., et al. Structures of sialylated O-linked oligosaccarides of bovine peripheral nerve α-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of α-dystroglycan with laminin. J Biol Chem. 272:1997;2156-2162.
19. Peng H.B., Dagget D.F., Rauvala H., Hassel J.R., Smalheiser N.R. The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Cell Adhes Commun. 5:1998;475-479.
20. Bowe M.A., Mendis D.B., Fallon J.R. The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle. J Cell Biol. 48:2000;801-810.
21. Michele D.E., Barresi R., Kanagawa M., et al. Post translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature. 418:2002;417-421.
22. Holt K.H., Crosbie R.H., Venzke D.P., Campbell K.P. Biosynthesis of dystroglycan: processing of a precursor propeptide. FEBS Lett. 468:2000;79-83.
23. Salih M.A., Sunada Y., Al-Nasser M., et al. Muscular dystrophy associated with beta-dystroglycan deficiency. Ann Neurol. 40:1996;925-928.
24. Hayashi Y.K., Ogawa M., Tagawa K., et al. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology. 57:2001;115-121.
25. Kano H., Kobayashi K., Herrmann R., et al. Deficiency of alpha-dystroglycan in muscle-eye-brain disease. Biochem Biophys Res Commun. 291:2002;1283-1286.
26. Beltrán-Valero de Bernabé D., Currier A., Steinbrecher A., et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet. 71:2002;1033-1043.
27. Dincer P., Leturcq F., Richard I., et al. A biochemical, genetic and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey. Ann Neurol. 42:1997;222-229.
28. Dincer P., Akçören Z., Demir E., et al. A cross section of autosomal recessive limb girdle muscular dystrophies in 38 families. J Med Genet. 37:2000;361-367.
29. Hillaire D., Helbling-Leclerc A., Faure S., et al. Localization of merosin negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet. 3:1994;1657-1661.
30. Helbling-Leclerc A., Topaloglu H., Tomer F.M., et al. Readjusting the localization of merosin (laminin alpha 2-chain) deficient congenital muscular dystrophy locus on chromosome 6q2. C R Acad Sci III. 318:1995;1245-1252.
31. Naom I.S., D'Alessandro M., Topaloglu H., et al. Refinement of the laminin alpha2 chain locus to human chromosome 6q2 in severe and mild merosin deficient congenital muscular dystrophy. J Med Genet. 34:1997;99-104.
32. Moghadaszadeh B., Desguerre I., Topaloglu H., et al. Identification of a new locus for a peculiar form of congenital muscular dystrophy with early rigidity of the spine, on chromosome 1p35-36. Am J Hum Genet. 62:1998;1439-1445.
33. Cormand B., Avela K., Pihko H., et al. Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage analysis and homozygosity mapping. Am J Hum Genet. 64:1999;126-135.
34. Toda T., Segawa M., Nomura Y., et al. Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nat Genet. 5:1993;283-286.
35. Dib C., Faure S., Fizames C., et al. A comprehensive genetic map of the human genome based on 5264 microsatellites. Nature. 380:1996;152-154.
36. Piccolo F., Roberds S.L., Jeanpierre M., et al. Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nat Genet. 10:1995;243-245.
37. Kessler S.W. Use of protein A-bearing staphylococci for the immunoprecipitation and isolation of antigens from cells. Methods Enzymol. 73:1981;442-459.
38. Herrmann R., Straub V., Blank M., et al. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Hum Mol Genet. 9:2000;2335-2340.
39. Winder S.J. The complexity of dystroglycan. Trends Biochem Sci. 26:2001;118-124.
40. Muntoni F., Brockington M., Torelli S., Blake D., Brown S. Defective glycosylation in muscular dystrophy. Lancet. 360:2002;1419-1421.
41. Kobayashi K., Nakahori Y., Miyake M., et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature. 394:1998;388-392.
42. Zaccaria M.L., Di Tommasa F., Brancaccio A., Paggi P., Petrucci T.C. Dystroglycan distribution in adult mouse brain: a light and electron microscopic study. Neuroscience. 104:2001;311-324.
43. Moore S.A., Salto F., Chen J., et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature. 418:2002;422-425.
44. Sugita S., Saito F., Tang J., Satz J., Campbell K., Südhof T.C. A stoichiometric complex of neurexins and dystroglycan in brain. J Cell Biol. 154:2001;435-445.